Log in to save to my catalogue

Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persiste...

Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persiste...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_aed1efd4c475448fb6f9f17a3d133860

Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study

About this item

Full title

Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2023-02, Vol.20 (1), p.38-38, Article 38

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Patients with human immunodeficiency virus-associated cryptococcal meningitis (HIV-CM) have persistent intracranial inflammation despite negative cerebrospinal fluid (CSF) fungal cultures after optimal treatment for CM, which could be devastating for the central nervous system. However, a definitive treatment strategy for persistent intracranial in...

Alternative Titles

Full title

Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_aed1efd4c475448fb6f9f17a3d133860

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_aed1efd4c475448fb6f9f17a3d133860

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-023-02717-w

How to access this item